JAPhA Practice Innovations最新文献

{"title":"Evaluating time to complete refill requests in primary care clinics with and without embedded pharmacists","authors":"Haylee Moser,&nbsp;Cheryl Maslouski,&nbsp;Addie Brown,&nbsp;Anna Gehres,&nbsp;Vedat Yildiz,&nbsp;Sonya Sebastian","doi":"10.1016/j.japhpi.2025.100085","DOIUrl":"10.1016/j.japhpi.2025.100085","url":null,"abstract":"<div><h3>Background</h3><div>In March 2022, Nationwide Children’s Hospital’s primary care clinic–embedded pharmacists became credentialed and privileged, allowing them to refill medications independently.</div></div><div><h3>Objectives</h3><div>The primary aim of this study is to evaluate and compare the time taken to complete medication refill requests between the primary care network (PCN) clinics with and without clinic-embedded pharmacists. Secondary objectives include comparing the time to authorize refill requests before and after pharmacist credentialing and quantifying refill requests addressed by pharmacists.</div></div><div><h3>Methods</h3><div>A retrospective review was conducted using an electronic health record data report for refill requests completed within the PCN from January 2020 to December 2024. This network comprises 14 clinics caring for children from birth to 21 years, one of which also cares for adults. Three clinics have a clinic-embedded pharmacist. The data report included patient age, clinic location, medication class, ordering provider credentials, and time to complete refill authorization requests. Requests for controlled medications and patients aged 21 years and older were excluded. Descriptive statistics and a generalized linear model were conducted for data analysis using SAS 9.4 (Cary, NC; 2016).</div></div><div><h3>Results</h3><div>From January 2020 to December 2024, clinics completed 38,057 refill requests. Clinics with a pharmacist completed requests in an average of 2.39 hours, and clinics without a pharmacist averaged 2.72 hours (<em>P</em> &lt; 0.0001). The difference in time to complete a request between clinics with and without a pharmacist during precredentialing years was 0.04 hours (2.27 vs. 2.31 hours) and 0.52 hours (2.47 vs. 2.99 hours) for postcredentialing years (<em>P</em> &lt; 0.0001). During the postcredentialing period, pharmacists fulfilled 2.9% of requests. On average, pharmacists authorized a request in 1.78 hours compared with other prescribers who averaged 2.88 hours (<em>P</em> &lt; 0.0001).</div></div><div><h3>Conclusion</h3><div>Primary care clinics with an embedded credentialed and privileged pharmacist took significantly less time to complete refill requests than clinics without a pharmacist.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"3 3","pages":"Article 100085"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implementing and evaluating point-of-care testing services in a rural independent community pharmacy","authors":"Brice Wagner,&nbsp;Justin Kirby","doi":"10.1016/j.japhpi.2026.100103","DOIUrl":"10.1016/j.japhpi.2026.100103","url":null,"abstract":"<div><h3>Background</h3><div>Pharmacists have increasingly expanded their scope of practice beyond medication dispensing, embracing roles such as immunizations and medication-therapy management. Point-of-care testing (POCT) represents the latest evolution, offering rapid diagnostics and timely interventions. State-specific pharmacist scope of practice laws across the country allow for various pharmacist-directed service lines. Many expansion opportunities exist, especially in rural areas.</div></div><div><h3>Objective</h3><div>This study aimed to evaluate patient acceptance, satisfaction, and perceptions of pharmacist-led POCT services provided at an independent rural pharmacy.</div></div><div><h3>Methods</h3><div>A prospective service evaluation was performed at an independent pharmacy in western Tennessee. Between November 2024 and March 2025, 36 patients visited the pharmacy-practice site with influenza, coronavirus disease 2019, or streptococcal pharyngitis symptoms and participated in pharmacist-led POCT. After the POCT encounter, patients completed an exit survey assessing satisfaction, perceived professionalism, likelihood of repeat use, and overall acceptance of pharmacist-provided testing. Survey data were analyzed using descriptive statistics.</div></div><div><h3>Results</h3><div>Of the 36 respondents, 35 (97%) rated their service experience highly (9 or 10 on a 10-point scale). Thirty-three patients (92%) indicated willingness to return for future testing under similar circumstances. All participants equated the professionalism of pharmacist-led POCT to that expected from traditional physician offices or urgent-care clinics. Convenience and rapid service were commonly cited advantages.</div></div><div><h3>Conclusion</h3><div>This study demonstrates high patient acceptance and satisfaction with pharmacist-led POCT in a rural pharmacy setting. The findings suggest that pharmacists are effectively positioned to address health care access issues in rural communities, providing a vital alternative to traditional health care facilities. Further support through policy development, training, and reimbursement optimization is essential to integrate and expand these services sustainably.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"3 3","pages":"Article 100103"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"College student attitudes and perceptions toward opioid overdose and harm reduction at a large, public university","authors":"Kaileigh D. Yen,&nbsp;Alexis Shook,&nbsp;Macary Weck Marciniak,&nbsp;Laura A. Rhodes","doi":"10.1016/j.japhpi.2025.100090","DOIUrl":"10.1016/j.japhpi.2025.100090","url":null,"abstract":"<div><h3>Background</h3><div>The number of college-aged students using illicit drugs has increased, alongside cases of polysubstance use and the addition of illegally manufactured fentanyl into other substances. Harm reduction strategies have been implemented to reduce overdose encounters. Literature has focused on college students’ knowledge of these topics; however, evidence is lacking regarding student attitudes toward opioid overdose risk and harm reduction tools and their perceptions and knowledge regarding access to those tools.</div></div><div><h3>Objective</h3><div>This study aimed to assess (1) student attitudes regarding opioid overdose and harm reduction and (2) perception and knowledge of access to these services at a public university.</div></div><div><h3>Methods</h3><div>This survey was conducted by an on-campus pharmacy at a large university in the southern United States. A 32-item survey was developed in Qualtrics and distributed using Listservs and e-mail groups and by posting flyers around campus. Those 18+ years and students enrolled at the university were included. The survey included 3 sections: (1) perceptions and attitudes, (2) supplemental questions, and (3) demographics. The survey remained open for 30 days. Results were analyzed using descriptive statistics.</div></div><div><h3>Results</h3><div>A total of 196 surveys were included. Most respondents were unlikely or very unlikely to obtain naloxone for themselves (n = 113, 58%); however, almost three-quarters (n = 136, 70%) indicated that they were very likely or likely to recommend obtaining naloxone to a friend. Of 174 comments provided, 64 (38%) mentioned a lack of knowledge of resources and 26 (18%) cited stigma as a barrier. Most respondents (n = 141, 72%) were unaware that naloxone is available free of charge from on-campus pharmacies.</div></div><div><h3>Conclusion</h3><div>Many college-aged students agreed that there is a risk of overdose on campus, a lack of knowledge about harm reduction tools, and a need to increase access to these tools. Students’ attitudes toward the need for harm reduction tools highlight a need for expanded education in this population.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"3 3","pages":"Article 100090"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of a pharmacist-led weight management service in patients with metabolic dysfunction–associated steatotic liver disease at outpatient clinics on the United States–Mexico border","authors":"Royce Li,&nbsp;Liliana Lunares,&nbsp;Karem E. Lambeth,&nbsp;Valerie M. Alvarado,&nbsp;Jacquelyn P. Navarrete,&nbsp;Bruno Hernandez Bizouarn,&nbsp;Alaa K. Abdelhakiem","doi":"10.1016/j.japhpi.2025.100082","DOIUrl":"10.1016/j.japhpi.2025.100082","url":null,"abstract":"<div><h3>Background</h3><div>Metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease, affects up to 30% of adults in the United States and is associated with an increased risk of cardiovascular disease, cancer, and end-stage liver disease. The University Medical Center (UMC) of El Paso consists of 6 community health clinics along the United States–Mexico border in El Paso, TX, serving a unique population addressing multiple conditions including MASLD.</div></div><div><h3>Objective</h3><div>This study aimed to investigate the efficacy of a pharmacist-led weight management service in patients with MASLD at an outpatient clinic on the United States–Mexico border.</div></div><div><h3>Methods</h3><div>Clinical pharmacists at UMC conducted a cohort study to assess the impact of pharmacist-led weight management on patients with MASLD. The primary outcomes were the improvement of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and FibroScan controlled attenuation parameter (CAP) scores. The secondary outcomes of this study were the decrease in weight, body mass index, and hemoglobin A1C.</div></div><div><h3>Results</h3><div>Of 669 chart reviews, 86 participants met the inclusion criteria. There was a statistically significant overall decrease in AST levels over a 7-month study period (<em>P</em> &lt; 0.001). However, both primary care providers (PCPs) and clinical pharmacist health care teams experienced similar reductions in AST, with a mean decrease of 13 units/liter and 8 units/liter, respectively (PCP vs. clinical pharmacist, <em>P</em> = 0.382). ALT levels also decreased significantly over the 7-month period (<em>P</em> &lt; 0.001), with a significant reduction observed in the clinical pharmacists compared with PCPs (13 vs. 6 units/liter, <em>P</em> = 0.023). Owing to incomplete data, analysis of FibroScan CAP scores was not performed. The results demonstrate that pharmacist involvement in MASLD care is associated with potential improvements in metabolic and hepatic parameters.</div></div><div><h3>Conclusion</h3><div>Both AST and ALT levels showed statistically significant reductions over a 7-month period. The significant decline in AST (<em>P</em> &lt; 0.001) across both groups suggests general hepatic improvement.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"3 3","pages":"Article 100082"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of community pharmacy outreach events to promote screening for human immunodeficiency virus","authors":"Destanie Truman,&nbsp;Robert Nichols,&nbsp;Stevie Veach,&nbsp;Enas M. Yehya,&nbsp;Matthew Witry","doi":"10.1016/j.japhpi.2026.100107","DOIUrl":"10.1016/j.japhpi.2026.100107","url":null,"abstract":"<div><h3>Background</h3><div>Human immunodeficiency virus (HIV) remains a prominent public health concern, with approximately 1.2 million individuals in the U.S. living with HIV and 13% unaware of their status. Community pharmacists are positioned to engage in HIV screening and education.</div></div><div><h3>Objectives</h3><div>The study aimed to (1) assess perceptions of HIV risk, HIV related knowledge, and public attitudes toward community pharmacist-provided HIV testing and (2) evaluate pharmacists offering HIV testing at community events.</div></div><div><h3>Methods</h3><div>A cross-sectional survey was administered to adults attending 3 community events where pharmacists were present to provide HIV education and testing. Participants completed an anonymous 16-item electronic survey via a quick-response code covering demographics, perceived risks, attitudes toward community pharmacist–provided HIV testing, and HIV knowledge. Descriptive statistics and multiple linear regression were used to analyze data. Impact was evaluated through the number of attendees and the number of HIV tests administered.</div></div><div><h3>Results</h3><div>Among 260 individuals who interacted with pharmacists, 58 completed the survey (response rate 22.3%). Most respondents were women (70.9%), aged 25-31 years, and white (76.4%). Perceived HIV risk was low, with 60% reporting that they were extremely unlikely to acquire HIV. The mean HIV knowledge score was 3.4 of 5, and 70% correctly identified Centers for Disease Control and Prevention testing recommendations. Attitudes toward pharmacist-provided HIV testing were generally positive, particularly when testing was offered at no cost. Multiple linear regression demonstrated that younger age was significantly associated with more favorable attitudes toward pharmacy-based HIV testing (<em>P</em> = 0.044). During the study period, 13 HIV tests were administered at community events.</div></div><div><h3>Conclusion</h3><div>Attendees of community outreach events were positive toward community pharmacists providing HIV education and testing. Community-based pharmacy outreach represents a promising approach to expand HIV testing access and normalize discussions around HIV prevention.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"3 3","pages":"Article 100107"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating provider satisfaction with the role of clinical pharmacists delivering chronic care management services within an accountable care organization","authors":"Courtney Whitfield,&nbsp;Anna Baird,&nbsp;Ashley Abode,&nbsp;Macary Weck Marciniak,&nbsp;Laura A. Rhodes","doi":"10.1016/j.japhpi.2026.100100","DOIUrl":"10.1016/j.japhpi.2026.100100","url":null,"abstract":"<div><h3>Background</h3><div>Chronic care management (CCM) involves coordinating comprehensive care for patients with multiple chronic conditions and focuses on addressing medical, functional, and psychosocial needs. This project describes an independent pharmacy that has delivered clinical services with a local accountable care organization (ACO). This collaboration has enabled clinical pharmacists to enhance patient care through medication expertise and patient relationships. Pharmacists facilitate communication with patients and care managers by remotely accessing electronic health records while providing the service. CCM services include reviewing medications and potential interactions, overseeing patient self-management of medications, and managing transitions of care.</div></div><div><h3>Objective</h3><div>This project aimed to assess provider perspectives on the role of the clinical pharmacist within the CCM model, access to a clinical pharmacist, and satisfaction with disease state impact and changes of care recommended by clinical pharmacists within an ACO.</div></div><div><h3>Methods</h3><div>A prospective, cross-sectional electronic survey was distributed to 32 ACO providers with pharmacists on their CCM teams. A 19-item survey captured provider perspectives on pharmacist contributions to CCM components. The survey was open for 30 days, with anonymized responses analyzed using descriptive statistics. Ranked responses were analyzed by generating a mean rank for each answer option, then ordered from low to high.</div></div><div><h3>Results</h3><div>Ten surveys were returned (response rate 31%). Most respondents were 46-65 years of age (n = 7, 70%) and physicians (n = 10, 100%), with 15+ years of practice experience (n = 8, 80%). The most impactful clinical pharmacy services were comprehensive medication reviews (mean, 2.7) and medication reconciliations (mean, 3.0). The top 5 disease states that clinical pharmacists affected were diabetes (mean, 2.7), atherosclerotic cardiovascular disease (mean, 3.9), chronic kidney disease (mean, 4.5), chronic obstructive pulmonary disease (mean, 5.4), and hypertension (mean, 6.0).</div></div><div><h3>Conclusion</h3><div>Providers expressed support for pharmacist-led services in CCM, highlighting pharmacists’ ability to enhance medication management, patient safety, and chronic disease outcomes.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"3 3","pages":"Article 100100"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of pharmacist immunization authority on infant respiratory syncytial virus immunoprophylaxis rates","authors":"CharLeigh Steverson,&nbsp;Amin Saiar,&nbsp;Robert Daniels,&nbsp;Elizabeth LaNou","doi":"10.1016/j.japhpi.2026.100091","DOIUrl":"10.1016/j.japhpi.2026.100091","url":null,"abstract":"<div><h3>Background</h3><div>Respiratory syncytial virus (RSV) is a common respiratory infection in infants that can result in serious complications and hospitalization. In July 2023, the Food and Drug Administration approved nirsevimab for RSV prevention in infants, and the Centers for Disease Control and Prevention (CDC) began tracking coverage rates through the RSV vaccination dashboard. Although pharmacists have been shown to improve vaccination rates in adults and children, the impact of pharmacist immunization authority (PIA) on infant RSV immunoprophylaxis rates has not been studied.</div></div><div><h3>Objective</h3><div>This study aimed to assess the impact of PIA on nirsevimab immunoprophylaxis rates in infants aged 0-7 months across U.S. jurisdictions during the 2024-2025 RSV season.</div></div><div><h3>Methods</h3><div>Publicly available data from the CDC RSV vaccination dashboard were analyzed to compare nirsevimab prophylaxis rates among infants across 28 jurisdictions from September 2024 to January 2025, categorized by PIA (independent, dependent, or none). Statistical analyses, including analysis of variance, post hoc <em>t</em> tests, and a Pearson chi-square test, were used to assess the relationship between PIA and immunoprophylaxis rates.</div></div><div><h3>Results</h3><div>Of the 28 jurisdictions included in the study, 9 had independent PIA, 8 had dependent authority, and 11 had no authority. The mean rate across all jurisdictions was 35% (SD 7%), with notable variability within each category of PIA. Statistical analyses showed no statistically significant difference in immunoprophylaxis rates by PIA category.</div></div><div><h3>Conclusion</h3><div>Although this study did not identify a statistically significant relationship between PIA and infant RSV immunoprophylaxis rates, jurisdictions requiring a patient-specific prescription had lower uptake than those with independent or no authority. This suggests that additional prescribing steps may limit timely access and highlights the need for strong pharmacist–physician collaboration. Although pharmacists did not shift rates during this early period, their involvement expands access points and may support improved uptake as implementation and authority become more consistent.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"3 3","pages":"Article 100091"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advanced roles for pharmacy technicians in North Carolina outpatient community-based pharmacies: A survey of pharmacists and pharmacy technicians","authors":"Andria Zuhlke,&nbsp;Laura Russell,&nbsp;Macary Weck Marciniak,&nbsp;Traci Shell,&nbsp;Laura A. Rhodes","doi":"10.1016/j.japhpi.2026.100113","DOIUrl":"10.1016/j.japhpi.2026.100113","url":null,"abstract":"<div><h3>Background</h3><div>Pharmacy technicians have traditionally assisted pharmacists with administrative medication dispensing tasks, but many are now being trained to serve in advanced roles supporting clinical services. However, the specific advanced tasks they perform and the benefits or barriers associated with these roles remain unclear.</div></div><div><h3>Objective</h3><div>To identify the roles and training methods offered by outpatient community-based pharmacies to pharmacy technicians and to identify perceived benefits and barriers for pharmacy technicians serving in advanced roles.</div></div><div><h3>Methods</h3><div>A cross-sectional, online survey was distributed to outpatient community-based pharmacists and pharmacy technicians in North Carolina whose sites employed at least one pharmacy technician. A 19-item investigator-developed survey explored technician roles, practice site-encouraged or supported training, and perceived benefits and barriers to pharmacy technicians in advanced roles. The survey was open for 30 days. Responses were analyzed using descriptive statistics and thematic analysis.</div></div><div><h3>Results</h3><div>Of 42,800 surveys distributed, 2663 were returned, and 1257 were included (pharmacists: n = 459; pharmacy technicians: n = 798). Commonly reported tasks performed were refill reminders (n = 1237, 98%), data entry (n = 1213, 96%), inventory management (n = 1203, 96%), and patient intake (n = 975, 78%). Encouraged or supported trainings at the practice site were continuing education (n = 1080, 86%), vaccine administration certificate training programs (n = 986, 78%), and cardiopulmonary resuscitation training (n = 874, 70%). Reported benefits were increased workflow efficiency (n = 645, 51%), increased personal or career satisfaction (n = 599, 48%), and increased workplace engagement (n = 555, 44%). Reported barriers were hiring shortages or high turnover (n = 591, 47%), lack of interest, engagement, or capacity (n = 574, 46%), and lack of incentive (n = 561, 45%).</div></div><div><h3>Conclusion</h3><div>North Carolina pharmacy technicians support pharmacists in tasks beyond medication dispensing, aided by practice site-supported training or education aligned with regulatory requirements. Findings suggest the need for solutions to address hiring shortages, a lack of interest, engagement, or capacity, and to incentivize those fulfilling advanced roles.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"3 3","pages":"Article 100113"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating patient perceived effectiveness, safety, and satisfaction with a pharmacist-led clinical wound care service","authors":"Victoria Pinkovsky,&nbsp;Traci Poole,&nbsp;Angela Hagan","doi":"10.1016/j.japhpi.2026.100112","DOIUrl":"10.1016/j.japhpi.2026.100112","url":null,"abstract":"<div><h3>Background</h3><div>Chronic wounds are associated with morbidity, reduced quality of life, and high healthcare costs. Topical antibiotics offer localized therapy, and community pharmacists can support patients through individualized therapy, education, and antimicrobial stewardship.</div></div><div><h3>Objectives</h3><div>To evaluate patient-reported outcomes on effectiveness, safety, and satisfaction with a pharmacist-led wound care service providing topical antibiotic therapy.</div></div><div><h3>Methods</h3><div>This cross-sectional survey study encompassed adults who had received pharmacist-recommended topical therapy in the preceding 90 days. Participants completed an anonymous Likert-scale survey assessing perceived therapy effectiveness, safety, and satisfaction using positively worded statements. Responses were recorded on a 5-point scale (1 = strongly agree to 5 = strongly disagree). Descriptive statistics summarized demographics and survey responses. Because satisfaction and effectiveness were assessed using Likert-scale items treated as continuous interval data, one-sample t-tests compared mean scores with the neutral midpoint (3) to determine whether patient perceptions differed significantly from neutrality. Chi-square goodness-of-fit tests evaluated categorical safety outcomes by comparing observed response distributions to an expected equal distribution across response categories. Internal consistency of the patient survey was assessed using Cronbach’s alpha.</div></div><div><h3>Results</h3><div>Of the 231 patients who were administered the survey, 94 met eligibility criteria and completed the survey to termination (40.69% response). Patients reported high perceived effectiveness in wound healing (mean = 1.69), smell (mean = 1.79), size (mean = 1.84), drainage (mean = 1.98), and pain (mean = 2.07) (all <em>P</em> &lt; 0.001). Safety data showed 17.02% (<em>P</em> &lt; 0.001) experienced application-site pain; 58.51% (<em>P</em> &lt; 0.005) had earlier systemic antibiotics. Satisfaction was high across communication (mean = 1.44), verbal (mean = 1.51) and written instructions (mean = 1.56), application (mean = 1.67), and affordability (mean = 1.82) (all <em>P</em> &lt; 0.001).</div></div><div><h3>Conclusion</h3><div>Pharmacist-recommended topical therapy for chronic, treatment-resistant wounds was associated with high satisfaction and perceived effectiveness, with few adverse events.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"3 3","pages":"Article 100112"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessing the effectiveness of patient-pharmacist communication during medication counseling in Texas community pharmacies","authors":"Kendall McKenzie,&nbsp;Amanda R. Stallings,&nbsp;Elizabeth Unni","doi":"10.1016/j.japhpi.2026.100106","DOIUrl":"10.1016/j.japhpi.2026.100106","url":null,"abstract":"<div><h3>Background</h3><div>Pharmacists, especially those in community settings, are well-positioned to reinforce medication understanding at the point of counseling, yet it remains unclear whether patients truly retain this information. There is a lack of understanding regarding the concordance between what pharmacists communicate and what patients perceive or recall.</div></div><div><h3>Objective</h3><div>To evaluate communication concordance between pharmacists and patients during counseling in community pharmacy settings.</div></div><div><h3>Methods</h3><div>A cross-sectional survey was conducted with 87 pharmacist–patient dyads across three Texas grocery store pharmacies. Both parties completed a five-item survey, including four closed-ended and one open-ended item. Concordance rates and demographic correlations were analyzed.</div></div><div><h3>Results</h3><div>Closed-ended item concordance was high (97.7%–100%), indicating strong agreement on structured counseling topics. Open-ended responses showed only 37.93% concordance, suggesting variability in perceived key takeaways. Patient age had a mild positive correlation with concordance (r = 0.324), while gender, ethnicity, insurance, and health literacy had no meaningful associations.</div></div><div><h3>Conclusion</h3><div>While pharmacists reliably deliver key medication information, discrepancies in open-ended recall point to a need for enhancing patient engagement and confirming understanding.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"3 3","pages":"Article 100106"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}